Annual Sickle Cell Disease and Thalassaemia Conference (ASCAT) 2020
The Annual Scientific Conference on Sickle Cell and Thalassaemia is one of the must attend events of the year for consultants and specialist psychologists, nurses, scientists and all relevant experts. The event is an ideal opportunity to see the latest advances in diagnosis, treatment and emerging fields in haemoglobinopathies. It is an opportunity to interact on the latest advances in clinical care, transition services and emerging new therapies including updates for curative treatment options. Furthermore, you will have the opportunity to show case your work through abstracts (oral and posters) and to network with leading and cutting edge practitioners.
Event Date: 29 Oct 2020 – 31 Oct 2020
Time: 8.30am – 16.30pm
Location: Park Plaza Westminster Bridge, 200 Westminster Bridge Road, London, GLN SE1 7UT
ASCAT Registration is OPEN! Please register via the link https://eur.cvent.me/DNRg
Online Registration Ends 25 October 2020
We understand the challenges everyone is facing during this unprecedented time, and as a team we are monitoring the situation, however we want to assure you that we are still continuing with our planning for this years conference and encourage you to register.
As we experience unprecedented times in the midst of a COVID-19 pandemic, I acknowledge that we are all facing different challenges and would therefore like to express my sincere best wishes and prayers for you all!
Looking forward to the 15th Annual Scientific Conference on Sickle Cell and Thalassaemia, the first joint initiative with two outstanding partners, European Hematology Association, for the 1st EHA European Sickle Cell Conference and British Society of Haematology, celebrating their 60th anniversary this year; I encourage you to seize this opportunity to engage with us as we bring the Sickle Cell and Thalassaemia family together!
Abstract and poster presentations will take place during the three day of this conference with an exciting opportunity for publication in both peer review journals (EHA and BSH). I am most looking forward to what we have committed to as being the biggest patient forum that this conference has ever seen. Patient involvement is key as we explore the emerging challenges and future therapies!
I am thrilled to be working with an expanded steering committee which includes renowned experts in Sickle Cell Disease, Thalassaemia and Psychology.